BioCentury | Dec 8, 2003
Finance

Restructuring watch

...facilities in North Carolina to Sweden. KARO acquired the U.S. facilities in its purchase of Novalon...
BioCentury | Nov 24, 2003
Company News

Karo Bio genomics, metabolic news

...and other research activities to Huddinge, Sweden. KARO acquired the facilities in its acquisition of Novalon Pharmaceutical Corp....
BioCentury | Nov 24, 2003
Finance

Ebb & Flow

...facilities in North Carolina to Sweden. KARO acquired the U.S. facilities via its purchase of Novalon...
BioCentury | Nov 18, 2003
Company News

Karo restructures

...in North Carolina to Huddinge, Sweden. KARO acquired the U.S. facilities in its purchase of Novalon...
BioCentury | Jan 29, 2001
Strategy

Bayer's value chain metrics

...48 12 12 1.32 Success rate 60% 25% 33% 11% Partners in space Millennium (MLNM) Novalon...
BioCentury | May 15, 2000
Company News

Karo Bio, Novalon deal

...completed its previously announced acquisition of Novalon in a stock transaction (see BioCentury, April 3). Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
...shares and own 20 percent of the combined company. Karo Bio AB (SSE:KARO), Stockholm, Sweden Novalon Pharmaceutical Corp....
BioCentury | May 10, 2000
Company News

Karo completes acquisition of Novalon

...completed its acquisition of Novalon , which was announced in March, via a stock transaction. Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
BioCentury | Apr 3, 2000
Company News

Karo Bio, Novalon deal

...developing nuclear receptor-targeted therapeutics using structure-based drug design, will acquire Novalon in a stock transaction. Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
...SEK200 million ($23.4 million) private placement with institutional investors. Karo Bio AB , Stockholm, Sweden Novalon Pharmaceutical Corp....
BioCentury | Apr 3, 2000
Finance

Janus denies any special insight

...announcing it will acquire U.S. nuclear receptor play Novalon in a stock transaction. On completion Novalon...
BioCentury | Mar 27, 2000
Company News

Karo to acquire Novalon

...receptor-targeted therapeutics using structure-based drug design, will acquire Novalon (Durham, N.C.) in a stock transaction. Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
...Torben Jorgensen will become CEO of Karo, replacing Per-Olof Martensson, who will become chairman, and Novalon...
Items per page:
1 - 10 of 32
BioCentury | Dec 8, 2003
Finance

Restructuring watch

...facilities in North Carolina to Sweden. KARO acquired the U.S. facilities in its purchase of Novalon...
BioCentury | Nov 24, 2003
Company News

Karo Bio genomics, metabolic news

...and other research activities to Huddinge, Sweden. KARO acquired the facilities in its acquisition of Novalon Pharmaceutical Corp....
BioCentury | Nov 24, 2003
Finance

Ebb & Flow

...facilities in North Carolina to Sweden. KARO acquired the U.S. facilities via its purchase of Novalon...
BioCentury | Nov 18, 2003
Company News

Karo restructures

...in North Carolina to Huddinge, Sweden. KARO acquired the U.S. facilities in its purchase of Novalon...
BioCentury | Jan 29, 2001
Strategy

Bayer's value chain metrics

...48 12 12 1.32 Success rate 60% 25% 33% 11% Partners in space Millennium (MLNM) Novalon...
BioCentury | May 15, 2000
Company News

Karo Bio, Novalon deal

...completed its previously announced acquisition of Novalon in a stock transaction (see BioCentury, April 3). Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
...shares and own 20 percent of the combined company. Karo Bio AB (SSE:KARO), Stockholm, Sweden Novalon Pharmaceutical Corp....
BioCentury | May 10, 2000
Company News

Karo completes acquisition of Novalon

...completed its acquisition of Novalon , which was announced in March, via a stock transaction. Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
BioCentury | Apr 3, 2000
Company News

Karo Bio, Novalon deal

...developing nuclear receptor-targeted therapeutics using structure-based drug design, will acquire Novalon in a stock transaction. Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
...SEK200 million ($23.4 million) private placement with institutional investors. Karo Bio AB , Stockholm, Sweden Novalon Pharmaceutical Corp....
BioCentury | Apr 3, 2000
Finance

Janus denies any special insight

...announcing it will acquire U.S. nuclear receptor play Novalon in a stock transaction. On completion Novalon...
BioCentury | Mar 27, 2000
Company News

Karo to acquire Novalon

...receptor-targeted therapeutics using structure-based drug design, will acquire Novalon (Durham, N.C.) in a stock transaction. Novalon...
...that bind to protein targets such as nuclear receptors, for pharmaceutical screening and target validation. Novalon...
...Torben Jorgensen will become CEO of Karo, replacing Per-Olof Martensson, who will become chairman, and Novalon...
Items per page:
1 - 10 of 32